Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerShanu Modi, David Cameron, William Jacot et al.|New England Journal of Medicine|2022Cited by 2.5k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerAntonino Glaviano, Alan Prem Kumar, Aaron Song Chuan Foo et al.|Molecular Cancer|2023Cited by 1.9k
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP. Tarantino, G. Curigliano, Giulia Viale et al.|Annals of Oncology|2023Cited by 298
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Julie A. Vendrell, Steven A. Narod et al.|European Journal of Cancer|2021Cited by 174
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor BiologyGaia Griguolo, Amélie Darlix, Stéphane Pouderoux et al.|The Oncologist|2018Cited by 45